In Biogen International GmbH v. Banner Live Sciences, LLC, [2020-1373] (April 21, 2020), the Federal Circuit affirmed the district court’s determination that Banner does not infringe the extended portion of U.S. Patent No. 7,691,001. The ‘001 patent covers the administration … Continue reading The Scope of Patent Term Extension under 35 USC §156 Only Includes the Active Ingredient of an Approved Product